- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about MRK
Recent news which mentions MRK
3 Forever Stocks to Buy With $100
September 05, 2023
From Motley Fool
Cancer Remains Pharma's Biggest Challenge And Mainz Biomed Has The Tool To Help Win The Battle
September 05, 2023
From Benzinga
Legal Twist In Drug Price Negotiation: Federal Judge Quits Case Amid Allegations Of Stock Ownership
September 05, 2023
From Benzinga
8 Pharma Stocks Affected by New Drug Price Negotiation Rules
September 02, 2023
From Motley Fool
From Motley Fool
Cannabis Industry's Capital Crunch: Why It Needs More Funds Than Other Industries, Will Fed Legalization Change This?
August 29, 2023
From Benzinga
Steady Eddies: 7 Unshakeable Stocks for Any Type of Market
August 29, 2023
From InvestorPlace
From MarketWatch
Better Pharma Growth Stock: Eli Lilly vs. Merck
August 29, 2023
From Motley Fool
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
August 28, 2023
From Benzinga
Viridian Chart Of The Week: How Capital Intensive Is Cannabis?
August 28, 2023
From Benzinga
A Step Closer To Cheaper Drugs For Americans: Price Negotiation And Its Implications
August 28, 2023
From Benzinga
Pharma Giants Unite Against Drug Price Negotiation: AstraZeneca Latest To Challenge The Government
August 25, 2023
From Benzinga
Merck/Eisai's Cancer Combo Therapy Ambition Dashed Once Again, Companies Throw Towel On Head & Neck Trial
August 25, 2023
From Benzinga
As Medicare picks 10 drugs for price negotiations, 50 million people stand to benefit — even if their drugs aren’t on the list
August 25, 2023
From MarketWatch
From MarketWatch
From Benzinga
Moderna Teams Up With Chinese Biotech To Assess Cell-Based Therapy And Cancer Vaccine Combo
August 21, 2023
From Benzinga
‘The sharks are still there.’ Stock market’s decline is just beginning, this top fund manager says
August 21, 2023
From MarketWatch
The 3 Most Undervalued Pharma Stocks to Buy Now: August 2023
August 21, 2023
From InvestorPlace
Merck Reveals Mixed Results From Pivotal Kidney Cancer Study Of Welireg In Pretreated Patients
August 18, 2023
From Benzinga
From Benzinga
The 3 Most Undervalued Penny Stocks to Buy Now: August 2023
August 14, 2023
From InvestorPlace
Buy Merck (MRK) Stock Now to Ride a Wave Higher in Healthcare
August 11, 2023
From InvestorPlace
The 3 Best ESG Stocks to Buy in August
August 10, 2023
From InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.